ShareCompartir
Announcement: Diabetes State Atlas Now Available Online
CDC's Division of Diabetes Translation announces the launch of the Diabetes State Atlas (available at http://www.cdc.gov/diabetes/data), an interactive Internet tool for the public to view maps and charts of diabetes data and trends at the U.S. state level. Some of the features of the atlas include 1) customizable maps and graphics of diabetes surveillance data, 2) an interactive application to view state-specific trends by age and sex, and 3) downloadable maps, charts, and data tables that can be used in grant applications, reports, articles, and publications.
The Diabetes State Atlas can help state public health officials document the burden of diabetes in their states, monitor trends, identify high-risk groups and assess disparities between groups, and track progress in achieving Healthy People 2020 diabetes objectives (1).
In the United States, about 29 million persons have diabetes (2). An additional 86 million adults have prediabetes, putting them at increased risk for developing type 2 diabetes, heart disease, and stroke (2). However, persons with diabetes can take steps to control the disease and prevent complications, and those with prediabetes can prevent or delay the onset of type 2 diabetes through weight loss and physical activity (3). Information about diabetes prevention and control is available online from CDC's Division of Diabetes Translation at http://www.cdc.gov/diabetes/home/index.html.
References
- US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2014. Available at https://www.healthypeople.gov.
- CDC. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. Available at http://www.cdc.gov/diabetes/pubs/statsreport14.htm.
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
